Singapore Medical Journal
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.7 | Q2 | 75.0% | 0.478 | Q3 | 59.3% |
| 2024 | 1.9 | Q2 | 67.9% | 0.420 | Q3 | 56.4% |
| 2023 | 1.7 | Q2 | 69.8% | 0.374 | Q3 | 55.5% |
| 2022 | 2.7 | Q2 | 77.0% | 0.398 | Q3 | 59.1% |
| 2021 | 3.3 | Q2 | 79.8% | 0.376 | Q3 | 58.4% |
| 2020 | — | — | 0.452 | Q3 | 63.2% | |
| 2019 | — | — | 0.450 | Q3 | 64.3% | |
| 2018 | — | — | 0.452 | Q2 | 62.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0037-5675
ISSN
2737-5935
region
Northern America
coverage
1960-2026